196 related articles for article (PubMed ID: 17237649)
1. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
[TBL] [Abstract][Full Text] [Related]
2. Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.
Katopodis KP; Elisaf M; Balafa O; Nikolopoulos P; Bairaktari E; Katsaraki A; Siamopoulos KC
Am J Nephrol; 2004; 24(5):469-73. PubMed ID: 15345918
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of low molecular weight heparin on lipid parameters in hemodialysis patients.
Elisaf MS; Bairaktari H; Germanos N; Pappas M; Koulouridis E; Papagalanis N; Siamopoulos KC
Int Angiol; 1996 Sep; 15(3):252-6. PubMed ID: 8971586
[TBL] [Abstract][Full Text] [Related]
5. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F
Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666
[TBL] [Abstract][Full Text] [Related]
6. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
Wiemer J; Scherberich JE
MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
[TBL] [Abstract][Full Text] [Related]
8. Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients.
Miyauchi H; Matsumoto Y; Futenma A; Amano I; Miyauchi J; Matsuo S
Ren Fail; 2006; 28(6):469-74. PubMed ID: 16928615
[TBL] [Abstract][Full Text] [Related]
9. [Lipid behavior during hemodialysis using heparin and prostacyclin].
Camici M; Evangelisti L
Minerva Med; 1992 Dec; 83(12):801-4. PubMed ID: 1491759
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of low molecular weight heparin on serum lipids in hypertriglyceridemic chronic hemodialysis patients.
Vlassopoulos D; Noussias C; Hadjipetrou A; Arvanitis D; Logothetis E; Magana P; Katopodis K; Hadjiconstantinou V
J Nephrol; 1997; 10(2):111-4. PubMed ID: 9238618
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal.
Chan MK; Varghese Z; Persaud JW; Baillod RA; Moorhead JF
Clin Nephrol; 1982 Apr; 17(4):183-90. PubMed ID: 7075035
[TBL] [Abstract][Full Text] [Related]
12. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
[TBL] [Abstract][Full Text] [Related]
13. The role of heparin in the changes of lipid patterns during a single hemodialysis.
Teraoka J; Matsui N; Nakagawa S; Takeuchi J
Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
Schmitt Y; Schneider H
Nephrol Dial Transplant; 1993; 8(5):438-42. PubMed ID: 8393549
[TBL] [Abstract][Full Text] [Related]
15. [Heparin and lipoprotein(a). Observations during hemodialysis].
Salvini P; Maddaloni E; Levi della Vida MV; Parma A; Corpetti MG; Di Lorenzo M
Recenti Prog Med; 1993 Dec; 84(12):828-33. PubMed ID: 8108596
[TBL] [Abstract][Full Text] [Related]
16. The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment.
Diepeveen SH; Verhoeven GH; van der Palen J; Dikkeschei BL; van Tits BL; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
Clin Chim Acta; 2005 Nov; 361(1-2):112-8. PubMed ID: 16122722
[TBL] [Abstract][Full Text] [Related]
17. The effect of heparin-free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment.
Matsui N; Nakamura Y; Shinoda T; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
Proc Eur Dial Transplant Assoc; 1980; 17():253-8. PubMed ID: 7243776
[TBL] [Abstract][Full Text] [Related]
18. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
19. Lipid and lipoprotein profile in physiological pregnancy.
Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
